INFUND HOLDING(SZ:002141)2025-04-30 09:42Group 1: Financial Performance - The company's net profit for 2024 was -113 million CNY, indicating a loss despite revenue growth [2] - The gross margin for the copper-clad laminate business in 2024 was 3.18%, with a net profit of -8.3 million CNY, primarily due to high initial investments for market expansion [3][4] Group 2: Business Strategy and Market Position - The company aims to improve profitability and gross margin through cost optimization, material cost control, and customer structure optimization [1] - The veterinary vaccine business is focusing on developing specialty products and implementing a "big product, big customer" strategy to enhance its market position over the next 3-5 years [2][3] Group 3: New Business Developments - The company has recently entered the copper-clad laminate and animal nutrition (feed) sectors, which are expected to have significant growth potential due to increasing demand in various industries [2][3] - The competitive advantages in the new businesses lie in production processes, management teams, and technological accumulation [2] Group 4: Future Outlook and Plans - The company plans to maintain stable operations in the feed business while actively expanding market reach and improving cost control to enhance profitability [4] - Future business development will focus on a dual main business model of "electronic information + animal health," leveraging technology to enhance industry positioning [4]